3-Methylanisole | CAS:100-84-5
            
            3-Methylanisole
            - 名称:间甲基苯甲醚; 3-甲基苯甲醚 | 3-Methylanisole
 - CAS号:100-84-5
 - 别名:1-Methoxy-3-methylbenzene; m-Methylanisole
 - 分子式:C8H10O
 - 分子量:122.17
 - EINESC号:202-893-4
 
产品描述
物理化学性质
| 沸点 | 175-176 ºC | 
|---|---|
| 闪点 | 54 ºC | 
| 密度 | 0.969 | 
| 折射率 | 1.512-1.514 | 
安全数据
| 危险品标志 | Xn | 
|---|---|
| 危险类别码 | R10;R22 | 
| 安全说明书 | S16;S23;S24/25 | 
SDS
| 来源 | SDS样本 | 
|---|---|
| 没有数据 | 没有数据 | 
产品合成路线
                | 名称 | CAS号 | 
|---|
更多
            文章
                同行评议文献
                
                                        Prediction of Setschenow constants of N-heteroaromatics in NaCl solutions based on the partial charge on the heterocyclic nitrogen atom.Bin Yang et al.Environmental science and pollution research international, 23(4), 3399-3405 (2015-10-23)
                                        [Studies on chemical constituents from roots of Peucedanum praeruptorum II].Cun Zhang et al.Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 31(16), 1333-1335 (2006-10-26)
                                        Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.Laura E Korhonen et al.Journal of medicinal chemistry, 48(11), 3808-3815 (2005-05-27)
                                        Bioactivation of Quinolines in a Recombinant Estrogen Receptor Transactivation Assay Is Catalyzed by N-Methyltransferases.Markus Brinkmann et al.Chemical research in toxicology, 32(4), 698-707 (2019-03-22)
                                        New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.L E Korhonen et al.British journal of pharmacology, 150(7), 932-942 (2007-02-28)
                                    
            备注
                
            Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
| 名称 | CAS号 | 
|---|
        
相关产品
相关资讯
问
    热门标签
    询 单
请 填 写 相 关 信 息
- 请填写产品名称!
 - CAS号
 - 请正确填写公司名称!
 - 请正确填写联系人!
 - 请正确填写联系电话!
 - 请正确填写联系邮箱!
 - 请描述您的问题!